Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure
- PMID: 10492795
- DOI: 10.1016/s0035-9203(99)90184-0
Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure
Abstract
The plasma concentrations of quinine and its main metabolite, 3-hydroxyquinine (3OHQn), were measured in 5 adult Thai patients with severe Plasmodium falciparum malaria and acute renal failure. Two patients required peritoneal dialysis but all survived. During acute renal failure plasma concentrations of 3OHQn rose to reach up to 45% of the levels of the parent compound. The estimated median (range) quinine clearance was 0.83 mL/kg/min (0.58-1.16), and 3OHQn clearance/fraction of quinine converted was 3.40 mL/kg/min (2.58-4.47). The estimated 3OHQn terminal elimination half-life was 21 h (16.5-32.5). These data suggest that 3OHQn contributes about 12% of the antimalarial activity of the parent compound in patients with falciparum malaria and acute renal failure. It is also likely that 3OHQn contributes to adverse effects, although this metabolite is not quantitated routinely by current high-performance liquid chromatography quinine assays.
Similar articles
-
Effects of cigarette smoking on quinine pharmacokinetics in malaria.Eur J Clin Pharmacol. 2002 Aug;58(5):315-9. doi: 10.1007/s00228-002-0447-4. Epub 2002 Jun 20. Eur J Clin Pharmacol. 2002. PMID: 12185554 Clinical Trial.
-
A study of the factors affecting the metabolic clearance of quinine in malaria.Eur J Clin Pharmacol. 1997;52(6):487-93. doi: 10.1007/s002280050323. Eur J Clin Pharmacol. 1997. PMID: 9342585
-
Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria.J Clin Pharm Ther. 2007 Feb;32(1):15-9. doi: 10.1111/j.1365-2710.2007.00788.x. J Clin Pharm Ther. 2007. PMID: 17286785 Clinical Trial.
-
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.Clin Pharmacokinet. 1996 Apr;30(4):263-99. doi: 10.2165/00003088-199630040-00002. Clin Pharmacokinet. 1996. PMID: 8983859 Review.
-
A case series of falciparum malaria-induced acute renal failure.Ann Acad Med Singap. 1999 Jul;28(4):578-82. Ann Acad Med Singap. 1999. PMID: 10561776 Review.
Cited by
-
Quinine clearance during continuous veno-venous high-volume hemofiltration.Intensive Care Med. 2008 Oct;34(10):1925-6. doi: 10.1007/s00134-008-1147-z. Epub 2008 May 17. Intensive Care Med. 2008. PMID: 18488191 No abstract available.
-
Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.J Am Soc Nephrol. 2020 Oct;31(10):2475-2489. doi: 10.1681/ASN.2020050564. Epub 2020 Sep 22. J Am Soc Nephrol. 2020. PMID: 32963091 Free PMC article.
-
Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria.Antimicrob Agents Chemother. 2003 May;47(5):1509-13. doi: 10.1128/AAC.47.5.1509-1513.2003. Antimicrob Agents Chemother. 2003. PMID: 12709315 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review.Malar J. 2022 Feb 10;21(1):41. doi: 10.1186/s12936-022-04065-1. Malar J. 2022. PMID: 35144612 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources